1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Smith, J.W. Le Calvez, H. Parra-Gessert, L. Preece, N.E. Jia, X. Assa-Munt, N. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic C2 H4 O 44.053 ACETYL GROUP non-polymer C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking H2 N 16.023 AMINO GROUP non-polymer C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US J.Biol.Chem. JBCHA3 0071 0021-9258 277 10298 10305 10.1074/jbc.M108071200 11748219 Selection and structure of ion-selective ligands for platelet integrin alpha IIb(beta) 3. 2002 10.2210/pdb1i6y/pdb pdb_00001i6y 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 1 SINGLE WAVELENGTH M 1 1.0 1324.555 ION-SELECTIVE LIGAND A1 1 syn polymer no yes (ACE)CRVVRGDYLDC(NH2) XCRVVRGDYLDCX A polypeptide(L) n n n n n n n n n n n n n database_2 pdbx_nmr_software pdbx_struct_assembly pdbx_struct_oper_list struct_conn struct_site repository Initial release Version format compliance Version format compliance Data collection Database references Derived calculations 1 0 2002-07-10 1 1 2008-04-27 1 2 2011-07-13 1 3 2022-02-23 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_nmr_software.name _struct_conn.pdbx_leaving_atom_flag _struct_site.pdbx_auth_asym_id _struct_site.pdbx_auth_comp_id _struct_site.pdbx_auth_seq_id NMR ENSEMBLE OF ION-SELECTIVE LIGAND A22 FOR PLATELET INTEGRIN ALPHAIIB-BETA3 NMR ENSEMBLE OF ION-SELECTIVE LIGAND D16 FOR PLATELET INTEGRIN ALPHAIIB-BETA3 NMR ENSEMBLE OF ION-SELECTIVE LIGAND D18 FOR PLATELET INTEGRIN ALPHAIIB-BETA3 RCSB Y RCSB 2001-03-06 REL REL The peptide was chemically synthesized: Commercial solid phase with cyclization via selective disulphide oxidation. sample These structures were determined using standard 2D homonuclear techniques (circa 2000). structures with the lowest energy 200 15 NOESY & DQF-COSY 3mg/ml 6.5 1 atm 278 K Ensemble A1 is based on a total of 117 NOE-derived distance constraints, 10 dihedral angle restraints, 1 covalent -SS- bonds and 1 VRGD, i,i+3 hydrogen bonds respectively. Refinements incorporated alpha proton and alpha, beta carbon shifts of 7-11 residues. restrained molecular dynamics and chemical shift refinement. 3mg/ml A1 20mM phosphate buffer; 90% H2O, 10% D2O Varian Inc. collection VNMR 6.1B Hare, D.; Biosym; MSI processing Felix 2000 Brunger, A. & Nilges, M. structure solution X-PLOR 3.8.5.1 Kuszweski, J. & Clore, G.M. refinement X-PLOR 3.8.5.1 (Chem.Shift.Module) 500 Varian UNITYPLUS ACE 1 n 1 ACE 1 A CYS 2 n 2 CYS 2 A ARG 3 n 3 ARG 3 A VAL 4 n 4 VAL 4 A VAL 5 n 5 VAL 5 A ARG 6 n 6 ARG 6 A GLY 7 n 7 GLY 7 A ASP 8 n 8 ASP 8 A TYR 9 n 9 TYR 9 A LEU 10 n 10 LEU 10 A ASP 11 n 11 ASP 11 A CYS 12 n 12 CYS 12 A CYS 12 n 13 NH2 13 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 1 A ARG 3 0.254 SIDE CHAIN 1 A ARG 6 0.315 SIDE CHAIN 2 A ARG 3 0.313 SIDE CHAIN 2 A ARG 6 0.317 SIDE CHAIN 3 A ARG 3 0.303 SIDE CHAIN 3 A ARG 6 0.310 SIDE CHAIN 4 A ARG 3 0.276 SIDE CHAIN 4 A ARG 6 0.299 SIDE CHAIN 5 A ARG 3 0.214 SIDE CHAIN 5 A ARG 6 0.317 SIDE CHAIN 6 A ARG 3 0.316 SIDE CHAIN 6 A ARG 6 0.310 SIDE CHAIN 7 A ARG 3 0.228 SIDE CHAIN 7 A ARG 6 0.290 SIDE CHAIN 8 A ARG 3 0.215 SIDE CHAIN 8 A ARG 6 0.316 SIDE CHAIN 9 A ARG 3 0.304 SIDE CHAIN 9 A ARG 6 0.305 SIDE CHAIN 10 A ARG 3 0.296 SIDE CHAIN 10 A ARG 6 0.295 SIDE CHAIN 11 A ARG 3 0.265 SIDE CHAIN 11 A ARG 6 0.316 SIDE CHAIN 12 A ARG 3 0.204 SIDE CHAIN 12 A ARG 6 0.246 SIDE CHAIN 13 A ARG 3 0.307 SIDE CHAIN 13 A ARG 6 0.189 SIDE CHAIN 14 A ARG 3 0.312 SIDE CHAIN 14 A ARG 6 0.317 SIDE CHAIN 15 A ARG 3 0.235 SIDE CHAIN 15 A ARG 6 0.214 SIDE CHAIN 1 A ARG 3 -90.49 -104.43 1 A ASP 8 -142.67 -10.35 1 A LEU 10 -100.24 -101.19 2 A VAL 4 -105.29 -94.60 2 A ASP 8 -160.29 83.99 2 A LEU 10 -148.80 14.70 3 A ASP 8 -119.21 66.71 3 A LEU 10 -98.20 39.57 4 A ASP 8 -160.35 90.12 4 A LEU 10 -117.98 64.19 5 A ARG 3 -104.98 -63.52 5 A VAL 4 -145.49 -159.63 5 A VAL 5 -136.89 -72.41 5 A ASP 8 -155.17 88.89 5 A LEU 10 -119.83 76.23 6 A LEU 10 -142.54 45.14 7 A LEU 10 -107.00 76.99 8 A ARG 3 -145.52 42.26 8 A VAL 5 -132.37 -121.18 8 A ASP 8 -150.05 77.47 8 A LEU 10 -142.82 50.09 9 A ASP 8 -115.39 64.36 10 A ARG 3 -146.20 36.94 10 A VAL 5 -141.10 -87.40 10 A LEU 10 -141.83 59.68 11 A ARG 3 -144.48 -25.72 11 A VAL 5 -136.01 -75.60 11 A ASP 8 -154.85 88.78 11 A LEU 10 -112.42 59.58 12 A ASP 8 -151.97 64.77 13 A LEU 10 -97.52 -145.00 14 A ARG 3 -143.70 23.41 14 A VAL 5 -142.39 -87.41 14 A ASP 8 -152.05 88.03 14 A LEU 10 -100.84 67.55 14 A ASP 11 -95.26 50.55 15 A VAL 5 -125.49 -84.39 15 A LEU 10 -95.19 46.60 NMR ENSEMBLE OF ION-SELECTIVE LIGAND A1 FOR PLATELET INTEGRIN ALPHAIIB-BETA3 1 N N disulf 2.022 A CYS 2 A SG CYS 2 1_555 A CYS 12 A SG CYS 12 1_555 covale 1.303 both A ACE 1 A C ACE 1 1_555 A CYS 2 A N CYS 2 1_555 covale 1.308 both A CYS 12 A C CYS 12 1_555 A NH2 13 A N NH2 13 1_555 CELL ADHESION integrin, RGD, CELL ADHESION 1I6Y PDB 1 1I6Y 1 13 1I6Y 1 13 1I6Y A 1 1 13 BINDING SITE FOR RESIDUE NH2 A 13 A NH2 13 Software 3 A TYR 9 A TYR 9 3 1_555 A ASP 11 A ASP 11 3 1_555 A CYS 12 A CYS 12 3 1_555